foxo4 dri for senescent cells Development of a novel senolytic by precise disruption of FOXO4-p53 complex FOXO4-DRI — ≥99% Purity, COA
Description
For a 250 mcg dose, draw 0.10 mL (10 units on an insulin syringe)
The information presented reflects clinical trial data available as of the publication date and may not reflect subsequent developments
Generally, TAMs are categorized into two main types: traditionally activated (M1-like macrophages) and alternatively activated (M2-like macrophages) [59]
Cell Metabolism , 35(2), 213-230
